What clinical trials are available for locally advanced Kidney Cancer

Clinical Trials for Locally Advanced Kidney Cancer

I appreciate your question about clinical trial options. Let me explain what "locally advanced" kidney cancer means and what the current treatment landscape looks like, including clinical trial opportunities.

Understanding Locally Advanced Kidney Cancer

Locally advanced kidney cancer typically refers to Stage III disease—tumors that have grown beyond the kidney itself but haven't spread to distant organs. This might include:

• Tumors extending into the renal vein or inferior vena cava (the large vein returning blood to the heart)
• Cancer that has spread to nearby lymph nodes
• Tumors that are large or have invaded surrounding tissues

Current Treatment Approaches (Per NCCN Guidelines)

According to the NCCN Guidelines for Kidney Cancer, the standard approach for locally advanced disease typically involves:

Primary Treatment:

• Surgical removal (nephrectomy - removal of the kidney) is usually the first step, often combined with removal of involved lymph nodes or vena caval thrombus if present

After Surgery - Adjuvant Therapy Options: For patients with clear cell kidney cancer who have high-risk features after surgery, the NCCN Guidelines recommend:

1. Pembrolizumab (an immunotherapy drug) - This is a Category 1 recommendation, meaning there is strong evidence supporting its use. The KEYNOTE-564 trial showed that pembrolizumab given after surgery improved disease-free survival compared to placebo.

2. Surveillance (careful monitoring without immediate treatment) - This remains an option for some patients

3. Clinical trials - Listed as an important option throughout the guidelines

Where to Find Clinical Trials

Important: The NCCN Guidelines specifically recommend that patients with locally advanced kidney cancer consider clinical trials as a preferred option at multiple decision points in their treatment.

To locate active clinical trials for your specific situation, I recommend:

• ClinicalTrials.gov - Search for "kidney cancer" + "locally advanced" or "stage III"
• Cancer.gov (National Cancer Institute) - Has a clinical trial finder
• Your cancer center - Ask your oncologist about trials they're actively enrolling in
• NCCN Member Institutions - Many major cancer centers participate in cutting-edge trials

Questions to Ask Your Oncology Team

Since clinical trials are specifically highlighted in the NCCN Guidelines for your situation, consider asking:

1. "Are there clinical trials available for my specific stage and type of kidney cancer?"
2. "What are the eligibility criteria, and do I qualify?"
3. "How does a trial option compare to standard adjuvant pembrolizumab for my case?"
4. "What would be the time commitment and potential side effects?"
5. "If I start a trial and it's not working, can I switch to standard treatment?"

Important Context

The field of kidney cancer treatment is rapidly evolving. According to the NCCN Guidelines, newer combination immunotherapy approaches (like nivolumab plus cabozantinib, or pembrolizumab plus axitinib) have shown strong results in advanced disease, and research continues to explore how these might benefit locally advanced patients as well.

Your oncologist can help determine whether a clinical trial might be appropriate for your specific situation, considering your overall health, kidney function, and other individual factors.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.